Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue 1, 2008, Pages 30-39

  Sbrana, Silverio ^a,c   Della Pina, Francesca ^a   Rizza, Antonio ^a   Buffa, Manuela ^a   De Filippis, Rossella ^a   Gianetti, Jacopo ^a   Clerico, Aldo ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c G PASQUINUCCI HOSPITAL   (Italy)

Author keywords

ADP; Anti aggregation therapies; Flow cytometry; Optical aggregometry; Platelet

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PADGEM PROTEIN; PLASMA PROTEIN; PROTEIN PAC 1; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CALCIUM MOBILIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; FEMALE; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; LOADING DRUG DOSE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD PLATELETS; CELL ADHESION MOLECULES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; DRUG THERAPY, COMBINATION; DUAL SPECIFICITY PHOSPHATASE 2; FEMALE; FLOW CYTOMETRY; HUMANS; IMAGE CYTOMETRY; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; P-SELECTIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TICLOPIDINE;

EID: 38349061853     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20360     Document Type: Article

References (27)

1. Woulfe D, Yang J, Prevost N, O'Brien PJ, Brass LF. Signal transduction during the initiation, extension, and perpetuation of platelet plug formation. In: Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002. pp 197-213.
2. McCabe White M, Jennings LK, editors. Basic introduction to platelets. Platelet Protocols, Research and Clinical Laboratory Procedures. San Diego, CA: Academic Press; 1999. pp 1-25.
3. Abrams CS. Intracellular signaling in platelets. Curr Opin Hematol 2005;12:401-405.
4. Kunapuli SP, Dorsam RT, Soochong K, Quinton TM. Platelet purinergic receptors. Curr Opin Pharmacol 2003;3:175-180.
5. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Lulius D, Conley PB. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001;409:202-207.
6. Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001;8:270-276.
7. 12 receptors at the level of calcium signaling in human platelets. Blood 2004;104:1745-1752.
8. Savi P, Pereillo JM, Uzabiaga MF, Combalbert J, Picard C, Maffrand JP, Pascal M, Herbert JM. Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 2000;84:891-896.
9. Waldmann R, Nieberding M, Walter U. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases. Eur J Biochem 1987;167:441-448.
10. Geiger J, Teichmann L, Grossmann R, Aktas B, Steigerwald U, Walter U, Schinzel R. Monitoring of clopidogrel action: Comparison of methods. Clin Chem 2005;51:957-965,
11. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005;3:85-92.
12. Watson JV. Proof without prejudice revisited: Immunofluorescence histogram analysis using cumulative frequency subtraction plus ratio analysis of means. Cytometry 2001;43:55-68.
13. Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J, De Filippis R, Clerico A. Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation. Cytometry Part B (Clinical Cytometry) 2005;65B:14-21.
14. Céu Monteiro M, Sansonetty F, Gonçalves MJ, O'Connor JE. Flow cytometric kinetic assay of calcium mobilization in whole blood platelets using Fluo-3 and CD41. Cytometry 1999;35:302-310.
15. 2-. Biochem J 1990;269:513-519.
16. Haugland RP. Loading and calibration of intracellular ion indicators. In: Spence MTZ, editor. The Molecular Probes Handbook, 10th ed. Carlsbad, CA: Invitrogen Corp; 2005. pp 881-882.
17. 2+ influx in rat endothelial cells. Circ Res 2003;92:286-292.
18. Tschoepe D, Spangenberg P, Esser J, Schwippert B, Keherel B, Roesen P, Gries FA. Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry 1990;11:652-656.
19. Oda A, Daley JF, Cabral C, Kang J, Smith M, Salzman EW. Heterogeneity in filamentous actin content among individual human blood platelets. Blood 1992;79:920-927.
20. 3. In: Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002. pp 197-213.
21. 3 internalization. J Thromb Haemost 2003;1:2404-2410.
22. Gurbel PA, O' Connor CM, Cummings CC, Serebruany VL. Clopidogrel: The future choice for preventing platelet activation during coronary stenting? Pharmacol Res 1999;40:107-111.
23. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
24. Bertrand ME, Rupprecht, Urban P, Gershlick AH; CLASSICS investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting; the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-629.
25. 12 receptor. Thromb Haemost 2006;96:767-773.
26. 12 receptor. Clin Chem 2006;52:383-388.
27. Dyszkiewicz-Korpanty AM, Frenkel EP, Sarode R. Approch to the assessment of platelet function: Comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 2005;11:25-35.